Atara Biotherapeutics
ATRA
ATRA
109 hedge funds and large institutions have $131M invested in Atara Biotherapeutics in 2023 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 118 → 109 (-9)
10% less capital invested
Capital invested by funds: $146M → $131M (-$15.3M)
45% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 20
Holders
109
Holding in Top 10
1
Calls
$1.82M
Puts
$98K
Top Buyers
| 1 | +$1.4M | |
| 2 | +$1M | |
| 3 | +$873K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$814K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$796K |
Top Sellers
| 1 | -$1.91M | |
| 2 | -$1.83M | |
| 3 | -$840K | |
| 4 |
D.E. Shaw & Co
New York
|
-$650K |
| 5 |
Goldman Sachs
New York
|
-$648K |